H.R. 7047 · 117th Congress · House

Lowering Costs by Improving Biosimilar Uptake Act

Active· Referred to the Subcommittee on Health.
Introduced
Mar 9, 22
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Lowering Costs by Improving Biosimilar Uptake Act

This bill allows for the omission of certain information relating to the strength of a product in a biosimilar application, as determined by the Food and Drug Administration.

Action Timeline

4
  1. MAR 10, 2022•Committee

    Referred to the Subcommittee on Health.

  2. MAR 09, 2022•IntroReferral

    Introduced in House

  3. MAR 09, 2022•IntroReferral

    Introduced in House

  4. MAR 09, 2022•IntroReferral

    Referred to the House Committee on Energy and Commerce.

Committees

2

Health Subcommittee

hsif14

Referred: Mar 10, 2022

Active

Energy and Commerce Committee

hsif00

Referred: Mar 9, 2022

Active